reference/1159251

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1159251

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	421
issn	1499-2752 0315-162X
issueIdentifier	3
pageRange	414-421
publicationName	The Journal of Rheumatology
startingPage	414
bibliographicCitation	Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Ligozio G, Mpofu S. One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study. J Rheumatol. 2014 Mar;41(3):414–21. doi: 10.3899/jrheum.130637. PMID: 24429175.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e338682ffe5694ec43760bc63af4d83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1760b34f4e9d808763fe2bc5a01cc01e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a767906419f05298e8f584de41c7781 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bd3d22df0ada08ac77ed12b900f9f7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c7fff423ad6cc433401e2a28c8f6292 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a92dc29e52e654b56cd4a06238c7bff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd7a19e7c9a13cfb202f130e2081fc9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5b504d8fb284e06bf713b69e9b8e525 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a613a46b3a885a9dcf83cb657f7703d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6f0b4e4a97f2b7f6c2fc2eb6139fc0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aacf0b3b82a3413128adac78314d1018 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4548200111fc67054553d5922fa3db7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d85a2bb8a1b1360b47b46bc8e4613ec1
date	2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3899/jrheum.130637 https://pubmed.ncbi.nlm.nih.gov/24429175
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243 https://portal.issn.org/resource/ISSN/1499-2752 https://portal.issn.org/resource/ISSN/0315-162X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
discusses	http://id.nlm.nih.gov/mesh/M0554163 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D018501Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D018501Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018501Q000009 http://id.nlm.nih.gov/mesh/D000911Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8214 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8592

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249565758

Total number of triples: 56.